Newron Pharmaceuticals S.p.A.
Status: Publicly traded
Direct answer
Newron Pharmaceuticals S.p.A. is publicly traded on SIX under the ticker NWRN.SW.
Founded in 1999 and headquartered in Bresso, Italy, Newron Pharmaceuticals S.p.A. is a clinical-stage biopharmaceutical enterprise focused on discovering and progressing therapeutic solutions. Its primary areas of research and development encompass conditions affecting the central and peripheral nervous systems, alongside pain management, with activities primarily conducted in Italy and the United States. The...
Can you invest in Newron Pharmaceuticals S.p.A.?
Yes. Newron Pharmaceuticals S.p.A. is publicly traded on SIX under the ticker NWRN.SW.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Newron Pharmaceuticals S.p.A.
Detailed equity research is provided by MarketSnap.